Search research articles
Contact Us
Filters
Showing results (71-80 of 152) with videos related to
Page
of 16
Sort By:
Cardiovascular and Interventional Radiology
|
May 8, 2019
Focus on Recommendations for the Management of Non-small Cell Lung Cancer
Pernelle Lavaud, Benjamin Besse, Thierry de Baere, et al.
European Journal of Immunology
|
August 2, 2017
High proportion of PD-1-expressing CD4<sup>+</sup> T cells in adipose tissue constitutes an immunomodulatory microenvironment that may support HIV persistence
Abderaouf Damouche, Guillaume Pourcher, Valérie Pourcher, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 11, 2026
Cytokines released by human tumors are independent from cancer histotype
Maria Kuksin, Severine Mouraud, Delphine Bredel, et al.
Anti-Cancer Drugs
|
October 27, 2016
Trabectedin in advanced desmoplastic round cell tumors: a retrospective single-center series
Benjamin Verret, Charles Honore, Sarah Dumont, et al.
Journal of Thoracic Disease
|
September 4, 2018
Endobronchial ultrasound-guided fine-needle aspiration for pulmonary carcinomas genotyping: experience with 398 cases including rapid <i>EGFR/KRAS</i> analysis in 43 cases
Maria-Rosa Ghigna, Adrian Crutu, Valentina Florea, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 17, 2021
A PD-1/PD-L1 Proximity Assay as a Theranostic Marker for PD-1 Blockade in Patients with Metastatic Melanoma
Isabelle Girault, Julien Adam, Shensi Shen, et al.
Cancers
|
November 13, 2021
CD8+ T Lymphocytes Immune Depletion and LAG-3 Overexpression in Hodgkin Lymphoma Tumor Microenvironment Exposed to Anti-PD-1 Immunotherapy
Jean-Marie Michot, Severine Mouraud, Julien Adam, et al.
Oncotarget
|
March 27, 2016
Phase I trial evaluating the antiviral agent Cidofovir in combination with chemoradiation in cervical cancer patients
Eric Deutsch, Christine Haie-Meder, Mohamed Amine Bayar, et al.
JAMA Oncology
|
June 30, 2017
Use of PD-1 Targeting, Macrophage Infiltration, and IDO Pathway Activation in Sarcomas: A Phase 2 Clinical Trial
Maud Toulmonde, Nicolas Penel, Julien Adam, et al.
The Oncologist
|
January 11, 2019
Brain Metastases and Place of Antiangiogenic Therapies in Alveolar Soft Part Sarcoma: A Retrospective Analysis of the French Sarcoma Group
Gabriel G Malouf, Guillaume Beinse, Julien Adam, et al.
Page
of 16
Search research articles
Search
Showing results (71-80 of 152) with videos related to
Sort By:
Page
of 16
Cardiovascular and Interventional Radiology
|
May 8, 2019
Focus on Recommendations for the Management of Non-small Cell Lung Cancer
Pernelle Lavaud, Benjamin Besse, Thierry de Baere, et al.
European Journal of Immunology
|
August 2, 2017
High proportion of PD-1-expressing CD4<sup>+</sup> T cells in adipose tissue constitutes an immunomodulatory microenvironment that may support HIV persistence
Abderaouf Damouche, Guillaume Pourcher, Valérie Pourcher, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 11, 2026
Cytokines released by human tumors are independent from cancer histotype
Maria Kuksin, Severine Mouraud, Delphine Bredel, et al.
Anti-Cancer Drugs
|
October 27, 2016
Trabectedin in advanced desmoplastic round cell tumors: a retrospective single-center series
Benjamin Verret, Charles Honore, Sarah Dumont, et al.
Journal of Thoracic Disease
|
September 4, 2018
Endobronchial ultrasound-guided fine-needle aspiration for pulmonary carcinomas genotyping: experience with 398 cases including rapid <i>EGFR/KRAS</i> analysis in 43 cases
Maria-Rosa Ghigna, Adrian Crutu, Valentina Florea, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 17, 2021
A PD-1/PD-L1 Proximity Assay as a Theranostic Marker for PD-1 Blockade in Patients with Metastatic Melanoma
Isabelle Girault, Julien Adam, Shensi Shen, et al.
Cancers
|
November 13, 2021
CD8+ T Lymphocytes Immune Depletion and LAG-3 Overexpression in Hodgkin Lymphoma Tumor Microenvironment Exposed to Anti-PD-1 Immunotherapy
Jean-Marie Michot, Severine Mouraud, Julien Adam, et al.
Oncotarget
|
March 27, 2016
Phase I trial evaluating the antiviral agent Cidofovir in combination with chemoradiation in cervical cancer patients
Eric Deutsch, Christine Haie-Meder, Mohamed Amine Bayar, et al.
JAMA Oncology
|
June 30, 2017
Use of PD-1 Targeting, Macrophage Infiltration, and IDO Pathway Activation in Sarcomas: A Phase 2 Clinical Trial
Maud Toulmonde, Nicolas Penel, Julien Adam, et al.
The Oncologist
|
January 11, 2019
Brain Metastases and Place of Antiangiogenic Therapies in Alveolar Soft Part Sarcoma: A Retrospective Analysis of the French Sarcoma Group
Gabriel G Malouf, Guillaume Beinse, Julien Adam, et al.
Page
of 16